Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 18 04:00PM ET
27.49
Dollar change
-0.08
Percentage change
-0.29
%
CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y9.73% Shs Outstand Perf Week-2.03%
SponsorFirst Trust ETF Type Tagsequity Return% 3Y2.84% Total Holdings51 Perf Month-1.12%
Fund Family Bond Type Tagspharmaceutical Return% 5Y6.28% AUM20.69M Perf Quarter4.52%
IndexNasdaq US Smart Pharmaceuticals Index Average Maturity Tagsgrowth Return% 10Y NAV% Perf Half Y4.13%
Index Weighting Commodity Type Tagsvalue Return% SI NAV/sh Perf Year6.67%
Active/Passive Quant Type Tagsvolatility Flows% 1M7.17% 52W Range23.85 - 28.41 Perf YTD3.29%
Dividend TTM0.41 (1.50%) ESG Type Tags- Flows% 3M-5.78% 52W High-3.24% Beta0.65
Dividend Ex-DateDec 22, 2023 Dividend Type Sector/Theme Flows% YTD7.15% 52W Low15.26% ATR (14)0.21
Expense0.60% Structure Type Region Flows% 1Y RSI (14)44.15 Volatility0.29% 0.57%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.18 Prev Close27.57
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume7.67K Price27.49
SMA20-1.58% SMA50-0.11% SMA2004.51% Trades Volume1,398 Change-0.29%
Nov-11-20 08:00AM
Feb-07-20 11:05AM
Nov-06-19 11:00AM
Sep-24-19 05:27PM
Aug-07-19 10:59AM
10:05AM Loading…
May-09-19 10:05AM
Mar-01-19 08:00AM
Feb-28-19 04:43PM
Feb-07-19 11:15AM
Jan-23-19 02:04PM
Oct-24-18 11:59AM
Oct-12-18 06:00AM
Jan-26-18 09:02AM
Jan-12-18 07:31AM
Jan-01-18 07:33AM
10:36AM Loading…
Sep-12-17 10:36AM
Sep-04-17 09:06AM
Sep-01-17 07:38AM
Aug-30-17 09:07AM
Aug-11-17 03:59PM
May-05-17 09:59AM
Mar-22-17 05:25PM
Dec-09-16 09:36AM
Oct-25-16 03:04PM
Oct-20-16 08:07AM
Oct-14-16 12:04PM
Sep-28-16 09:00AM
Sep-27-16 09:00AM
Sep-22-16 01:55PM
Sep-21-16 09:12AM
First Trust Nasdaq Pharmaceuticals ETF seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals IndexTM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified.